摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-n-propyl-3H-pyrazolo[1,5-a][1,3,5]triazin-4-one | 934524-67-1

中文名称
——
中文别名
——
英文名称
2-n-propyl-3H-pyrazolo[1,5-a][1,3,5]triazin-4-one
英文别名
2-propyl-3H,4H-pyrazolo[1,5-a][1,3,5]triazin-4-one;2-propyl-3H-pyrazolo[1,5-a][1,3,5]triazin-4-one
2-n-propyl-3H-pyrazolo[1,5-a][1,3,5]triazin-4-one化学式
CAS
934524-67-1
化学式
C8H10N4O
mdl
——
分子量
178.194
InChiKey
MLGRZOIZAMNFHI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    59.3
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-n-propyl-3H-pyrazolo[1,5-a][1,3,5]triazin-4-one四氯化锡三氯氧磷 作用下, 以 氯仿 为溶剂, 生成 [4-(N-methylanilino)-2-propylpyrazolo[1,5-a][1,3,5]triazin-8-yl]-phenylmethanone
    参考文献:
    名称:
    Efficient synthesis of 8-substituted pyrazolo[1,5-a]-1,3,5-triazines by regioselective acylation
    摘要:
    An efficient two-step synthesis of 8-acylated pyrazolo[1,5-a]-1,3,5-triazines has been accomplished. The key strategic elements of this novel synthetic approach involve the use of the N-methyl-N-phenylamino activating group, which was easily obtained in high yield by treatment of the pyrazolotriazin-4-one with phosphorus oxychloride and dimethylaniline through high pressure reaction coupled with a regioselective acylation at position 8 followed by the subsequent displacement of the N-methyl-N-phenylamino group upon treatment with various amines. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(02)02456-5
  • 作为产物:
    参考文献:
    名称:
    Pyrazolotriazines
    摘要:
    具有特定化学式I的化合物,其中R1、R2、A、R4、B、R5和R6的含义如描述中所示,是具有抗增殖和/或诱导凋亡活性的有效化合物。
    公开号:
    EP2070932A1
点击查看最新优质反应信息

文献信息

  • Synthesis of 8-Substituted Pyrazolo[1,5-<i>a</i>]-1,3,5-triazine Derivatives by Palladium-Catalyzed Cross-Coupling Reactions
    作者:Benoît Joseph、Florence Popowycz、Philippe Bernard、Pierre Raboisson
    DOI:10.1055/s-2006-958963
    日期:2007.2
    8-Substituted pyrazolo[1,5-a]-1,3,5-triazine derivatives 6 were prepared from the corresponding 8-iodopyrazolo[1,5-a]-1,3,5-triazines 5 through palladium-catalyzed cross-coupling reactions. Several bioisosteres of hypoxanthine drugs 2 were then prepared by final nucleophilic aromatic substitution.
    8-取代的吡唑并[1,5-a]-1,3,5-三嗪衍生物6由相应的8-碘吡唑并[1,5-a]-1,3,5-三嗪5通过钯催化交叉制备-偶联反应。然后通过最终的亲核芳香取代制备了几种次黄嘌呤药物 2 的生物等排体。
  • Cyclic nucleotide phosphodiesterase type 4 inhibitors: Evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere
    作者:Pierre Raboisson、Dominique Schultz、Christian Muller、Jean-Marie Reimund、Guillaume Pinna、Romain Mathieu、Philippe Bernard、Quoc-Tuan Do、Renee L. DesJarlais、Hélène Justiano
    DOI:10.1016/j.ejmech.2007.05.016
    日期:2008.4
    5-a]-1,3,5-triazines were considered as a bioisosteric replacement for the 9-substituted adenine derivatives resulting in the discovery of 8-(2-methoxybenzyl)-4-(N-methylamino)-2-n-propylpyrazolo[1,5-a]-1,3,5-triazine (14d) and 2-trifluoromethyl-8-(2-methoxybenzyl)-4-(N-methylamino)pyrazolo[1,5-a]-1,3,5-tria zine (14e) as a new structural class of potent phosphodiesterase type 4 inhibitors (IC(50)=13
    一系列的8-取代的吡唑并[1,5-a] -1,3,5-三嗪被认为是9-取代的腺嘌呤衍生物的生物立体替代品,从而发现了8-(2-甲氧基苄基)-4- (N-甲基氨基)-2-正丙基吡唑并[1,5-a] -1,3,5-三嗪(14d)和2-三氟甲基-8-(2-甲氧基苄基)-4-(N-甲基氨基)吡唑并[1,5-a] -1,3,5-三嗪(14e)作为具有强同工酶选择性的新型4类有效磷酸二酯酶抑制剂(IC(50)= 13 nM和11 nM)。反应的原始串联涉及容易获得的8-碘-2-甲基-4-(N-甲基-N-苯基氨基)吡唑并[1,5-a] -1的钯介导的交叉偶联反应(PMCCR) ,3,5-三嗪(11a)和芳基硼酸或炔烃,然后置换N-甲基-N-苯基氨基,是本文开发的新型合成方法中的关键步骤。用n-BuLi和选定的醛处理11a-c代表了PMCCR有趣的替代方法,用于合成苄基衍生物14a-i。初步生物学测试表明
  • [EN] PYRAZOLOTRIAZINES<br/>[FR] PYRAZOLOTRIAZINES
    申请人:4SC AG
    公开号:WO2009074677A2
    公开(公告)日:2009-06-18
    Compounds of a certain formula I, in which R1, R2, A, R4, B, R5 and R6 have the meanings indicated in the description, are effective compounds with antiproliferative and/or apoptosis inducing activity.
  • Pyrazolotriazines
    申请人:4SC AG
    公开号:EP2070932A1
    公开(公告)日:2009-06-17
    Compounds of a certain formula I, in which R1, R2, A, R4, B, R5 and R6 have the meanings indicated in the description, are effective compounds with anti-proliferative and/or apoptosis inducing activity.
    具有特定化学式I的化合物,其中R1、R2、A、R4、B、R5和R6的含义如描述中所示,是具有抗增殖和/或诱导凋亡活性的有效化合物。
  • Efficient synthesis of 8-substituted pyrazolo[1,5-a]-1,3,5-triazines by regioselective acylation
    作者:Pierre Raboisson、Dominique Schultz、Claire Lugnier、Jean-Jacques Bourguignon
    DOI:10.1016/s0040-4039(02)02456-5
    日期:2002.12
    An efficient two-step synthesis of 8-acylated pyrazolo[1,5-a]-1,3,5-triazines has been accomplished. The key strategic elements of this novel synthetic approach involve the use of the N-methyl-N-phenylamino activating group, which was easily obtained in high yield by treatment of the pyrazolotriazin-4-one with phosphorus oxychloride and dimethylaniline through high pressure reaction coupled with a regioselective acylation at position 8 followed by the subsequent displacement of the N-methyl-N-phenylamino group upon treatment with various amines. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

酪氨酸,2-甲氧基-O-甲基- 达美司特 百里酚-6-磺化三(2-羟基乙基)铵 吡唑并[1,5-a][1,3,5]噻嗪-4(3H)-酮 吡唑并[1,5-a][1,3,5]三嗪-2,4-二胺 吡唑并[1,5-D][1,2,4]三嗪酮 吡唑并[1,5-A]-1,3,5-三嗪-2,4(1H,3H)-二酮 N4-(1,1-二甲基乙基)-7-甲基吡唑并(1,5-a)-1,3,5-三嗪-2,4-二胺盐酸盐 N'-甲酰基-4-氨基吡唑并[5,1-c][1,2,4]三嗪-3-甲酰肼 8-苄基-2-甲基-4-(N-甲基氨基)吡唑并[1,5-a]-1,3,5-三嗪 8-溴-4-氯-2-(甲基硫代)吡唑并[1,5-a][1,3,5]三嗪 7-甲基-6H-吡唑并[4,5-e][1,2,3]三嗪-4-酮 7-甲基-1,7-二氢-4H-吡唑并[3,4-d][1,2,3]三嗪-4-酮2-氧化物 7-(叔丁基)吡唑并[1,5-a][1,3,5]三嗪-4(3H)-酮 5,6-二氢吡唑并[1,5-d][1,2,4]三嗪-4,7-二酮 4-甲氧基吡唑并[1,5-a][1,3,5]三嗪 4-氯-2-(甲硫基)吡唑并[1,5-a][1,3,5]三嗪 4-氨基-7-甲基吡唑并[5,1-C][1,2,4]三嗪-3-甲腈 4,7-二甲基吡唑并[5,1-c][1,2,4]三嗪-3-羧酸乙酯 4,7-二甲基吡唑并[5,1-C][1,2,4]三嗪-3-羧酸 4,6-二氢-6-(碘乙酰基)-3-甲基-4-亚甲基吡唑并[5,1-c][1,2,4]三嗪 3-甲氧基-2H-吡唑并[4,3-e][1,2,4]三嗪 3-(1,1-二甲基乙基)-7-(5-甲基-3-异恶唑基)-2-[(1-甲基-1H-1,2,4-三唑-5-基)甲氧基]吡唑并[1,5-d][1,2,4]三嗪 3,4-二甲基吡唑并[5,1-c][1,2,4]三嗪 2-甲基吡唑并[1,5-d][1,2,4]三嗪-4(5H)-酮 2-甲基-4-(N-甲基氨基)-8-[(2-噻吩基)甲基]吡唑并[1,5-a]-1,3,5-三嗪 2-Thi氧代-2,3-二氢吡唑并[1,5-a][1,3,5]噻嗪-4(1H)-酮 2-(甲基硫代)吡唑并[1,5-a][1,3,5]噻嗪-4(3H)-酮 2,4-二氨基-吡唑并(1,5-a)-S-三嗪盐酸盐半水合物 2,4-二(甲基氨基)-7-甲基吡唑并(1,5-a)-S-三嗪 1-(4,7-二甲基吡唑并[5,1-c][1,2,4]三氮杂-3-基)-1-乙酮 4-(2,4-dichlorophenyl)-8-(3-pentyl)-7-ethyl-2-methyl-pyrazolo[1,5-a]-1,3,5-triazine 2-(4-tert-butylphenyl)-4-({3-[(2,3-dihydro-1H-inden-2-yl)amino]-2,2-difluoropropyl}amino)-6H,7H-pyrazolo[1,5-a][1,3,5]triazin-7-one 2-(4-tert-butylphenyl)-4-{[3-(dimethylamino)propyl]amino}-8-[(6-methylpyridin-3-yl)methyl]-6H,7H-pyrazolo[1,5-a][1,3,5]triazin-7-one 4-methyl-N-(1-methyl-1-phenylethyl)-2-phenyl-1,2,3,4-tetrahydropyrazolo[5,1-c][1,2,4]triazine-8-carboxamide 2,4-diphenyl-pyrazolo[1,5-a][1,3,5]triazine 3H-8-carbonitrile-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-7-methylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-8-carboxylic acid ethyl ester 2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-7-trifluoromethylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-8-methylpyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-2-(5-chlorouracil-6-methylthio)-8-iodopyrazolo[1,5-a][1,3,5]triazin-4-one 3H-8-chloro-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 3H-8-bromo-2-(5-chlorouracil-6-methylthio)pyrazolo[1,5-a][1,3,5]triazin-4-one 6-[4-(1-hydroxy-1-methylethyl)phenyl]-2-methyl-5H-1,5,7,7a-tetraazainden-4-one Pyrazolo<3,2-f><1,2,4>triazin-4(3H)-on methyl 3,7-dimethyl-4-oxo-4,6-dihydro-pyrazolo[5,1-c][1,2,4]triazine-8-carboxylate 2-(4-tert-butylphenyl)-4-{[3-(4-chloro-3-methylphenoxy)propyl]sulfanyl}-6H,7H-pyrazolo[1,5-a] [1,3,5]triazin-7-one